The Valley Desk

ReviewJournal of pharmaceutical sciencesPublished

Review of dose justifications for antibody-drug conjugate approvals from clinical pharmacology perspective: A focus on exposure-response analyses

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Review
Venue
Journal of pharmaceutical sciences
Published
Subject terms
Animals; Humans; Neoplasms; Antineoplastic Agents; Immunoconjugates; Risk Assessment; Drug Approval; Pharmacology, Clinical; Dose-Response Relationship, Drug; Pharmacokinetics; Pharmacodynamics; Cancer Chemotherapy
PubMed ID
39374692
Added to directory
Source checked

Report a correction or request removal